Suppr超能文献

致癌潜能与受体酪氨酸激酶中致癌单、双体种系突变的激活效应有关。

Oncogenic potential is related to activating effect of cancer single and double somatic mutations in receptor tyrosine kinases.

机构信息

National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland 20894, USA.

出版信息

Hum Mutat. 2012 Nov;33(11):1566-75. doi: 10.1002/humu.22145. Epub 2012 Jul 16.

Abstract

Aberrant activation of receptor tyrosine kinases (RTKs) is a common feature of many cancer cells. It was previously suggested that the mechanisms of kinase activation in cancer might be linked to transitions between active and inactive states. Here, we estimate the effects of single and double cancer mutations on the stability of active and inactive states of the kinase domains from different RTKs. We show that singleton cancer mutations destabilize active and inactive states; however, inactive states are destabilized more than the active ones, leading to kinase activation. We show that there exists a relationship between the estimate of oncogenic potential of cancer mutation and kinase activation. Namely, more frequent mutations have a higher activating effect, which might allow us to predict the activating effect of the mutations from the mutation spectra. Independent evolutionary analysis of mutation spectra complements this observation and finds the same frequency threshold defining mutation hotspots. We analyze double mutations and report a positive epistasis and additional advantage of doublets with respect to cancer cell fitness. The activation mechanisms of double mutations differ from those of single mutations and double mutation spectrum is found to be dissimilar to the mutation spectrum of singletons.

摘要

受体酪氨酸激酶(RTKs)的异常激活是许多癌细胞的共同特征。先前有人提出,癌症中激酶激活的机制可能与活性和非活性状态之间的转换有关。在这里,我们估计单癌突变和双癌突变对不同 RTK 的激酶结构域的活性和非活性状态稳定性的影响。我们表明,单癌突变会使活性和非活性状态失稳;然而,非活性状态的失稳程度超过活性状态,导致激酶激活。我们表明,癌症突变的致癌潜力估计与激酶激活之间存在关系。即,更频繁的突变具有更高的激活作用,这可能使我们能够根据突变谱预测突变的激活作用。对突变谱的独立进化分析补充了这一观察结果,并发现了定义突变热点的相同频率阈值。我们分析了双突变,并报告了正的上位效应,以及双突变体相对于癌细胞适应性的额外优势。双突变的激活机制与单突变不同,并且双突变谱与单突变体的突变谱不同。

相似文献

3
Effects of oncogenic mutations on the conformational free-energy landscape of EGFR kinase.
Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10616-21. doi: 10.1073/pnas.1221953110. Epub 2013 Jun 10.
4
A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors.
Oncogene. 2007 Jun 7;26(27):3909-19. doi: 10.1038/sj.onc.1210173. Epub 2007 Feb 26.
5
Structural and clinical consequences of activation loop mutations in class III receptor tyrosine kinases.
Pharmacol Ther. 2018 Nov;191:123-134. doi: 10.1016/j.pharmthera.2018.06.016. Epub 2018 Jun 30.
7
Tyrosine kinase mutations in human cancer.
Curr Mol Med. 2007 Feb;7(1):77-84. doi: 10.2174/156652407779940486.
9
ROS1 Fusions Rarely Overlap with Other Oncogenic Drivers in Non-Small Cell Lung Cancer.
J Thorac Oncol. 2017 May;12(5):872-877. doi: 10.1016/j.jtho.2017.01.004. Epub 2017 Jan 11.

引用本文的文献

3
PremPS: Predicting the impact of missense mutations on protein stability.
PLoS Comput Biol. 2020 Dec 30;16(12):e1008543. doi: 10.1371/journal.pcbi.1008543. eCollection 2020 Dec.
4
Limitations and challenges in protein stability prediction upon genome variations: towards future applications in precision medicine.
Comput Struct Biotechnol J. 2020 Jul 24;18:1968-1979. doi: 10.1016/j.csbj.2020.07.011. eCollection 2020.
5
Computational Approaches to Prioritize Cancer Driver Missense Mutations.
Int J Mol Sci. 2018 Jul 20;19(7):2113. doi: 10.3390/ijms19072113.
6
Mutational signatures and mutable motifs in cancer genomes.
Brief Bioinform. 2018 Nov 27;19(6):1085-1101. doi: 10.1093/bib/bbx049.
10
ProKinO: a unified resource for mining the cancer kinome.
Hum Mutat. 2015 Feb;36(2):175-86. doi: 10.1002/humu.22726.

本文引用的文献

1
Predicting folding free energy changes upon single point mutations.
Bioinformatics. 2012 Mar 1;28(5):664-71. doi: 10.1093/bioinformatics/bts005. Epub 2012 Jan 11.
3
The energy landscape analysis of cancer mutations in protein kinases.
PLoS One. 2011;6(10):e26071. doi: 10.1371/journal.pone.0026071. Epub 2011 Oct 6.
4
Predicting the functional impact of protein mutations: application to cancer genomics.
Nucleic Acids Res. 2011 Sep 1;39(17):e118. doi: 10.1093/nar/gkr407. Epub 2011 Jul 3.
5
In silico and in vitro investigations of the mutability of disease-causing missense mutation sites in spermine synthase.
PLoS One. 2011;6(5):e20373. doi: 10.1371/journal.pone.0020373. Epub 2011 May 27.
6
Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms.
Mol Cell. 2011 Apr 8;42(1):9-22. doi: 10.1016/j.molcel.2011.03.004.
7
Database resources of the National Center for Biotechnology Information.
Nucleic Acids Res. 2011 Jan;39(Database issue):D38-51. doi: 10.1093/nar/gkq1172. Epub 2010 Nov 21.
8
BioRuby: bioinformatics software for the Ruby programming language.
Bioinformatics. 2010 Oct 15;26(20):2617-9. doi: 10.1093/bioinformatics/btq475. Epub 2010 Aug 25.
9
Computational analysis of missense mutations causing Snyder-Robinson syndrome.
Hum Mutat. 2010 Sep;31(9):1043-9. doi: 10.1002/humu.21310.
10
Performance of protein stability predictors.
Hum Mutat. 2010 Jun;31(6):675-84. doi: 10.1002/humu.21242.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验